Study: NCT03098641

Adverse event: Ureteric injury
Serious: yes
Organ System: Renal and urinary disorders
Notes: perioperative complication
Frequency: 2 affected / 272 at risk

Adverse event: Urinary tract infection
Serious: yes
Organ System: Renal and urinary disorders
Notes: perioperative complication
Frequency: 2 affected / 272 at risk

Adverse event: Post procedural haematoma
Serious: yes
Organ System: Renal and urinary disorders
Notes: postoperative complication in the month following the surgery
Frequency: 2 affected / 272 at risk

Adverse event: Vaginal prolapse
Serious: yes
Organ System: Renal and urinary disorders
Notes: Of the 272 patients included, 220 were reviewed at more than one month postoperatively. The description of adverse events is therefore only available for these patients.
Frequency: 7 affected / 220 at risk

Adverse event: Medical device site reaction
Serious: yes
Organ System: Renal and urinary disorders
Notes: Of the 272 patients included, 220 were reviewed at more than one month postoperatively. The description of adverse events is therefore only available for these patients.
Frequency: 2 affected / 220 at risk

Adverse event: Bladder injury
Serious: no
Organ System: Renal and urinary disorders
Frequency: 3 affected / 272 at risk

Adverse event: Rectal injury
Serious: no
Organ System: Renal and urinary disorders
Frequency: 1 affected / 272 at risk

Adverse event: Urinary retention postoperative
Serious: no
Organ System: Renal and urinary disorders
Frequency: 19 affected / 272 at risk

Adverse event: Pain
Serious: no
Organ System: Renal and urinary disorders
Frequency: 103 affected / 272 at risk

Adverse event: Urinary tract infection
Serious: no
Organ System: Renal and urinary disorders
Frequency: 15 affected / 272 at risk

Adverse event: Post procedural haematoma
Serious: no
Organ System: Renal and urinary disorders
Frequency: 6 affected / 272 at risk

Adverse event: Pain
Serious: no
Organ System: Renal and urinary disorders
Notes: Of the 272 patients included, 220 were reviewed at more than one month postoperatively. The description of adverse events is therefore only available for these patients.
Frequency: 7 affected / 220 at risk

Adverse event: Medical device site reaction
Serious: no
Organ System: Renal and urinary disorders
Notes: Of the 272 patients included, 220 were reviewed at more than one month postoperatively. The description of adverse events is therefore only available for these patients.
Frequency: 8 affected / 220 at risk

Adverse event: Medical device site granuloma
Serious: no
Organ System: Renal and urinary disorders
Notes: Of the 272 patients included, 220 were reviewed at more than one month postoperatively. The description of adverse events is therefore only available for these patients.
Frequency: 6 affected / 220 at risk

Adverse event: Incontinence
Serious: no
Organ System: Renal and urinary disorders
Notes: Of the 272 patients included, 220 were reviewed at more than one month postoperatively. The description of adverse events is therefore only available for these patients.
Frequency: 10 affected / 220 at risk

Adverse event: Vaginal prolapse
Serious: no
Organ System: Renal and urinary disorders
Notes: Of the 272 patients included, 220 were reviewed at more than one month postoperatively. The description of adverse events is therefore only available for these patients.
Frequency: 4 affected / 220 at risk

Adverse event: Dyspareunia
Serious: no
Organ System: Renal and urinary disorders
Notes: Of the 272 patients included, 220 were reviewed at more than one month postoperatively. The description of adverse events is therefore only available for these patients.
Frequency: 1 affected / 220 at risk